3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Plasma cell
1
Head & Neck
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
923
Lung Neoplasms
626
Small Cell Lung Carcinoma
172
Colorectal Neoplasms
136
Melanoma
110
Breast Neoplasms
108
Neoplasms
98
Ovarian Neoplasms
94
Neoplasm Metastasis
91
Pancreatic Neoplasms
77
Squamous Cell Carcinoma of Head and Neck
70
Stomach Neoplasms
60
Carcinoma, Renal Cell
58
Head and Neck Neoplasms
57
Triple Negative Breast Neoplasms
51
Esophageal Neoplasms
51
Endometrial Neoplasms
51
Prostatic Neoplasms
47
Uterine Cervical Neoplasms
44
Colonic Neoplasms
43
Urinary Bladder Neoplasms
41
Mesothelioma
41
Mesothelioma, Malignant
38
Carcinoma, Hepatocellular
38
Brain Neoplasms
34
Sarcoma
30
Carcinoma, Transitional Cell
29
Adenocarcinoma of Lung
29
Lung Diseases
26
Disease
26
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Thoracic
×
90 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled